Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder

Journal of Clinical Investigation

Volumn 99, Issue 5, 1997, Pages 1028-1036

  Freeman, Michael R ^a,b   Yoo, James J ^a   Raab, Gerhard ^b   Soker, Shay ^b   Adam, Rosalyn M ^a   Schneck, Francis X ^a   Renshaw, Andrew A ^a,c   Klagsbrun, Michael ^a,b   Atala, Anthony ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

cell proliferation; EGF receptor; ErbB; HER1; urinary tract; urothelium

Indexed keywords

DIPHTHERIA TOXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; MESSENGER RNA;

ARTICLE; BLADDER; CELL CULTURE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SMOOTH MUSCLE FIBER; TISSUE REGENERATION; UROTHELIUM;

EID: 0030981338     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119230     Document Type: Article

References (62)

1. Martin, B.F. 1972. Cell replacement and differentiation in transitional epithelium: A histological and autoradiographic study of the guinea pig bladder and ureter. J. Anat. 112:433-455.
2. Chodak, G.W., Y. Shing, M. Borge, S.M. Judge, and M. Klagshrun. 1986. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancers. Cancer Res. 46:5507-5510.
3. Chodak, G.W., V. Hospelhorn, S.M. Judge, R. Mayforth, H. Koeppen, and J. Sasse. 1988. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res. 48:2083-2088.
4. Yura, Y., O. Hayashi, M. Kelly, and R. Oyasu. 1989. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary functions. Cancer Res. 49:1548-1553.
5. Chopin, D.K., J.-P. Caruelle, M. Colombel, S. Palcy, V. Ravery, D. Caruelle, C.C. Abbou, and D. Barritault. 1993. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J. Urol. 150:1126-1130.
6. Nguyen, M., H. Watanabe, A.E. Budson, J.P. Richie, and J. Folkman. 1993. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst. 85:241-242.
7. Hirao, Y., K. Izumi, and R. Oyasu. 1980. The effect of normal rat urine on mucosal regeneration in heterotopic urinary bladder. Lab. Invest. 42:76-84.
8. Rowland, R.G., M.O. Henneberry, R. Oyasu, and J.T. Grayhack. 1980. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res. 40:4524-4527.
9. Oyasu, R., Y. Hirao, and K. Izumi. 1981. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res. 41:478-481.
10. Hayashi, O., S. Noguchi, and R. Oyasu. 1987. Transferrin as a growth factor for rat bladder carcinoma cells in culture. Cancer Res. 47:4560-4564.
11. Momose, H., H. Kakinuma, S.Y. Shariff, G.B. Mitchell, A. Rademaker, and R. Oyasu. 1991. Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis. Cancer Res. 51:5487-5490.
12. Kuranami, M., K. Yamaguchi, M. Fuchigami, K. Imanishi, T. Watanabe, K. Abe, F. Asanuma, and Y. Hiki. 1991. Effect of urine on clonal growth of human bladder cancer cell lines. Cancer Res. 51:4631-4635.
13. Lau, J.L., J.E. Fowler, Jr., and L. Ghosh. 1988. Epidermal growth factor in the normal and neoplastic kidney and bladder. J. Urol. 139:170-175.
14. Noguchi, S., Y. Yura, E.R. Sherwood, H. Kakinuma, N. Kashihara, and R. Oyasu. 1990. Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor. Lab. Invest. 62:538-544.
15. Messing, E.M., P. Hanson, P. Ulrich, and E. Erturk. 1987. Epidermal growth factor - interactions with normal and malignant urothelium: in vivo and in situ studies. J. Urol. 138:1329-1335.
16. Parries, G., K. Chen, K.S. Misono, and S. Cohen. 1995. The human urinary epidermal growth factor (EGF) precursor: Isolation of a biologically active 160 kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus. J. Biol. Chem. 270:27954-27960.
17. Ward, S., D. Dykoski, J. Harvey, and G.A. Niehans. 1994. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: A multivariate survival analysis. Am. J. Clin. Pathol. 101:166-176.
18. Ravery, V., M. Colombel, Z. Popov, S. Bastuji, J.J. Patard, J. Bellot, C.C. Abbou, Y. Fradet, and D.K. Chopin. 1995. Prognostic value of epidermal growth factor-receptor. T138 and T43 expression in bladder cancer. Br. J. Cancer. 71:196-200.
19. Imai, T., M. Kimura, M. Takeda, and Y. Tomita. 1995. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder. Br. J. Cancer. 71:69-72.
20. Mellon, K., C. Wright, P. Kelly, C.H. Horne, and D.E. Neal. 1995. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J. Urol. 153:919-925.
21. Sauter, G., J. Haley, K. Chew, R. Kerschmann, D. Moore, P. Carroll, H. Moch, F. Gudat, M.J. Mihatsch, and F. Waldman. 1994. Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int. J. Cancer. 57:508-514.
22. Dubeau, L., and P.A. Jones. 1987. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res. 47:2107-2112.
23. Messing, E.M., and C.A. Reznikoff. 1987. Normal and malignant human urothelium: In vitro effects of epidermal growth factor. Cancer Res. 47:2230-2235.
24. Cilento, B.G., M.R. Freeman, F.X. Schneck, A.B. Retik, and A. Atala. 1994. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J. Urol. 152:665-670.
25. Besner, G., S. Higashiyama, and M. Klagsbrun. 1990. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1:811-819.
26. Higashiyama, S., J.A. Abraham, J. Miller, J.C. Fiddes, and M. Klagsbrun. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science (Wash. DC). 251:936-939.
27. Higashiyama, S., K. Lau, G.E. Besner, J.A. Abraham, and M. Klagsbrun. 1992. Structure of heparin-binding EGF-like growth factor: multiple forms, primary structure, and glycosylation of the mature protein. J. Biol. Chem. 267: 6205-6212.
28. Yoshizumi, M., S. Kourembanas, D.H. Temizer, R.P. Cambria, T. Quertermous, and M.-E. Lee. 1992. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J. Biol. Chem. 267:9467-9469.
29. Dluz, S.M., S. Higashiyama, D. Damm, J.A. Abraham, and M. Klagsbrun. 1993. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J. Biol. Chem. 268:18330-18334.
30. + T cells. Proc. Natl. Acad. Sci. USA. 91:2890-2894.
31. Miyagawa, J., S. Higashiyama, S. Kawata, Y. Inui, S. Tamura, K. Yamamoto, M. Nishida, T. Nakamura, S. Yamashita, Y. Matsuzawa, et al. 1995. Localisation of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J. Clin. Invest. 95:404-411.
32. Powell, P.P., M. Klagsbrun, J.A. Abraham, and R.C. Jones. 1993. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am. J. Pathol. 143:784-793.
33. Naglich, J.G., J.E. Metherall, D.W. Russell, and L. Eidels. 1992. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor. Cell. 69:1051-1061.
34. Mitamura, T., S. Higashiyama, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1995. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J. Biol. Chem. 270:1015-1019.
35. Higashiyama, S., J.A. Abraham, and M. Klagsbrun. 1993. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122: 933-940.
36. Hashimoto, K., S. Higashiyama, H. Asada, E. Hashimura, T. Kobayashi, K. Sudo, T. Nakagawa, D. Damm, K. Yoshikawa, and N. Taniguchi. 1994. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for keratinocytes. J. Biol. Chem. 269:20060-20066.
37. Higashiyama, S., R. Iwamoto, K. Goishi, G. Raab, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1995. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membane-anchored heparin-binding EGF-like growth factor. J. Cell Biol. 128:929-938.
38. Goishi, K., S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, M. Ishikawa, E. Mekada, and N. Taniguchi. 1995. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol. Biol. Cell. 6:967-980.
39. Shishido, Y., K.D. Sharman, S. Higashiyama, M. Klagsbrun, and E. Mekada. 1995. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin receptor/membrane-anchored epidermal growth factor-like growth factor. J. Biol. Chem. 270:29578-29585.
40. Aviezer, D., and A. Yayon. 1994. Heparin-dependent binding and auto-phosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc. Natl. Acad. Sci. USA. 91: 12173-12177.
41. Parsons, C.L. 1994. A model for the function of glycosaminoglycans in the urinary tract. World J. Urology. 12:38-42.
42. Grist, M., and J. Chakraborty. 1994. Identification of a mucin layer in the urinary bladder. Urology. 44:26-33.
43. Elgebaly, S.A., M.E. Allam, M.P. Walzak, Jr., D. Oselinsky, C. Gillies, and H. Yamase. 1992. Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation. J. Urol. 147:1382-1387.
44. Christmas, T.J. 1994. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br. J. Urol. 73:508-515.
45. Deleted in proof.
46. Chen, X., G. Raab, U. Deutsch, J. Zhang, R.M. Ezzell, and M. Klagsbrun. 1995. Induction of heparin-binding EGF-like growth factor expression during myogenesis: Activation of the gene by MyoD and localization of the transmembrane form of the protein at the myotube surface. J. Biol. Chem. 270: 18285-18294.
47. Chomczynski, P., and N. Sacchi. 1987. Single-step method for RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:156-159.
48. Freeman, M.R., D.J. Bagli, C.C. Lamb, P.D. Guthrie, T. Uchida, R.E. Slavin, and L.W.K. Chung. 1994. Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression. J. Cell. Physiol. 158:325-336.
49. Masui, H., A. Wells, C.S. Lazar, M.G. Rosenfeld, and G.N. Gill. 1991. Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. Cancer Res. 51:6170-6175.
50. 165 via its exon 7-encoded domain. J. Biol. Chem. 271: 5761-5767.
51. Denizot, F., and R. Lang. 1986. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods. 89:271-277.
52. Temizer, D.H., M. Yoshizumi, M.A. Perrella, E.E. Susanni, T. Quertermous, and M.-E. Lee. 1992. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 267:24892-24896.
53. Raab, G., S. Higashiyama, S. Hetelekidis, J.A. Abraham, D. Damm, M. Ono, and M. Klagsbrun. 1994. Biosynthesis and processing by phorbol ester of the cell surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem. Biophys. Res. Comm. 204:592-597.
54. Beerli, R.R., and N.E. Hynes. 1996. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J. Biol. Chem. 271:6071-6076.
55. Elenius, K., S. Paul, G. Allison, J. Sun, and M. Klagsbrun. 1997. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO (Eur. Mol. Biol. Organ.) J. In press.
56. Mesri, E.A., M. Ono, R.J. Kreitman, M. Klagsbrun, and I. Pastan. 1994. The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans. J. Cell Sci. 107:2599-2608.
57. Peoples, G.E., S. Blotnick, K. Takahashi, M.R. Freeman, M. Klagsbrun, and T.J. Eberlein. 1995. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc. Natl. Acad. Sci. USA. 92:6547-6551.
58. Marikovsky, M., K. Breuing, P.Y. Liu, E. Eriksson, S. Higashiyama, P. Farber, J. Abraham, and M. Klagsbrun. 1993. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc. Natl. Acad. Sci. USA. 90:3889-3893.
59. Freeman, M.R., M. Ishikawa, A.A. Renshaw, S.M. Dethlefsen, M. Kaefer, and M. Klagsbrun. 1996. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is synthesized by smooth muscle cells in the human prostate. J. Urol. 155:323A.
60. Iwamoto, R., S. Higashiyama, T. Mitamura, N. Taniguchi, M. Klagsbrun, and E. Mekada. 1994. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO (Eur. Mol. Biol. Organ.) J. 13:2322-2330.
61. Nakamura, K., R. Iwamoto, and E. Mekada. 1995. Membrane-anchored EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell Biol. 129:1691-1705.
62. Rolf, J.M., H.M. Gaudin, and L. Eidels. 1990. Localization of the diphtheria toxin receptor-binding domain to the carboxyl-terminal Mr ∼ 6000 region of the toxin. J. Biol. Chem. 265:7331-7337.